Commentary On Infertility and Restorative Reproductive Medicine
DOI:
https://doi.org/10.63264/7eg52623Keywords:
infertility, restorative reproductive medicineAbstract
In 1972, a seminal article was published demonstrating that women, adequately trained, could detect the approach of ovulation in the fertile window of their menstrual cycle. It was demonstrated that the symptoms perceived by women at the vulva correlate closely with changes in steroid hormone levels associated with folliculogenesis and the luteal phase. The fertility charting performed by women trained to recognize vulvar symptoms associated with hormonal changes serves as an instrument for detecting potential pathologies and monitoring the effects of treatment These findings established the biological foundations of a tool of fertility awareness tracking that has facilitated the development of restorative reproductive medicine (RRM): an approach that can be applied to identify and treat the underlying causes of infertility/subfertility.
Several core characteristics—or foundational pillars—of the RRM approach to fertility can be identified. These include: a commitment to respecting healthy physiological processes, comprehensive health care for both the couple and the potential embryo, and the provision of education and continuous support throughout the therapeutic process.
This commentary aims to elucidate the interplay of these foundational pillars by drawing upon evidence from peer-reviewed biomedical literature. Finally, the challenges faced by RRM in strengthening its scientific foundations, engaging with the broader scientific community, and promoting the dissemination of this approach are described.
References
1. Billings EL, Brown JB, Billings JJ, Burger HG. Symptoms and hormonal changes accompanying ovulation. Lancet 1972;1: 282-284. doi: 10.1016/s0140-6736(72)90291-7.
2. Hilgers TW, Prebil AM. The ovulation method--vulvar observations as an index of fertility/infertility. Obstet Gynecol 1979;53: 12-22.
3. Hilgers TW, ed. The medical and surgical practice of NaProTechnology. Omaha (NE): Pope Paul VI Institute Press; 2004.
4. Duane M, Stanford JB, Porucznik CA, Vigil P. Fertility Awareness-Based Methods for Women's Health and Family Planning. Front Med (Lausanne). 2022 May 24;9:858977. doi: 10.3389/fmed.2022.858977.
5. Brown JB. Types of ovarian activity in women and their significance: the continuum (a reinterpretation of early findings). Hum Reprod Update. 2011 Mar-Apr;17(2):141-58. doi: 10.1093/humupd/dmq040. Epub 2010 Oct 5.
6. Boyle P, Andralojc K, van der Velden S, Najmabadi S, de Groot T, Turczynski C, Stanford JB. Restoration of serum estradiol and reduced incidence of miscarriage in patients with low serum estradiol during pregnancy: a retrospective cohort study using a multifactorial protocol including DHEA. Front Reprod Health. 2024 Jan 4;5:1321284. doi: 10.3389/frph.2023.1321284.
7. Stanford JB, Parnell TA, Boyle PC. Outcomes from treatment of infertility with natural procreative technology in an Irish general practice. J Am Board Fam Med. 2008 Sep-Oct;21(5):375-84. doi: 10.3122/jabfm.2008.05.070239. Erratum in: J Am Board Fam Med. 2008 Nov-Dec;21(6):583.
8. Stanford JB, Parnell T, Kantor K, et al. International Natural Procreative Technology Evaluation and Surveillance of Treatment for Subfertility (iNEST): enrollment and methods. Hum Reprod Open. 2022 Aug 9;2022(3):hoac033. doi: 10.1093/hropen/hoac033.
9. Stanford JB, Carpentier PA, Meier BL, Rollo M, Tingey B. Restorative reproductive medicine for infertility in two family medicine clinics in New England, an observational study. BMC Pregnancy Childbirth. 2021 Jul 7;21(1):495. doi: 10.1186/s12884-021-03946-8.
10. Ben Messaoud K, Bouyer J, Guibert J, de La Rochebrochard E. The burden of very early dropout in infertility care: a nationwide population-based cohort study. Hum Reprod. 2024 Jan 5;39(1):102-107. doi: 10.1093/humrep/dead226.
11. Understanding the success of Assisted Reproductive Techniques, REDLARA (Internet) Cited: March 2025, Available from: https://redlara.org/Entendendo-o-sucesso-das-Tecnicas-de-Reproducao-Assistida.asp
12. ART Success Rates. Assisted Reproductive Technology. CDC Article (Internet) Cited March 2025. Available from: https://art.cdc.gov/#/
13. Fertility treatment 2022: Preliminary trends and Figures, Human Fertilisation and Embryology Authority (Internet). Cited: March 2025. Available at: https://www.hfea.gov.uk/about-us/publications/research-and-data/fertility-treatment-2022-preliminary-trends-and-figures/#section-1
Published
Issue
Section
Categories
License
Copyright (c) 2025 José Antonio Arraztoa (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
CC-BY-4.0 permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.